EU Drug Launches Could Be Deprioritized As Pharma Seeks To ‘Placate’ Trump

 
• By Eliza Slawther
  
Threats of US tariffs on pharma imports could see the EU deprioritized when it comes to drug launches (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access